Analysis of the correlation between Gal-3 expression level in the primary tumors and the patients′ clinicopathological features revealed no remarkable association between Gal-3 expression and age, gender, T stage, tumor subtype, and lymphovascular invasion (Table 1). This evidence concerns the gene LGALS3 and neoplasm.